Atrys Health SA

As of June 30, 2026, Atrys Health SA carries a market capitalization of 192.45M, placing it among publicly traded companies globally. Its enterprise value stands at 298.44M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Atrys Health SA's next confirmed earnings release is scheduled for March 3, 2027.

As of June 30, 2026, Atrys Health SA has 75.92M shares outstanding.

These figures are as of June 30, 2026.

As of June 30, 2026, Atrys Health SA maintains a current ratio of 0.47, meaning it holds 0.5x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended June 30, 2026.

As of the close on October 22, 2026, Atrys Health SA's stock has declined approximately 25.64% over the past 52 weeks. The 50-day moving average sits at 2.62, while the 200-day moving average is 2.74.

As of June 30, 2026, Atrys Health SA holds 12.50M in cash and equivalents against 118.43M in total debt, resulting in a net debt position of 78.29M. Total book value stands at 147.43M, with working capital of -63.02M providing operational flexibility.

Atrys Health SA's most recent stock split took place on October 24, 2019 with a 71:72 split ratio.